<DOC>
	<DOCNO>NCT02554721</DOCNO>
	<brief_summary>The primary objective study investigate effect Cilostazol , Acetylsalycylic acid Clopidogrel alone well combination Cilostazol/Acetylsalicylic acid Cilostazol/ Clopidogrel ex-vivo Platelet Function ( PF ) testing .</brief_summary>
	<brief_title>Pharmacodynamic Study Cilostazol Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Cilostazol</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Healthy Caucasian male subject Able read , write fully understand German language Provision write informed consent screen baseline BMI 19.0 30.0 kg/m2 , inclusive body weight 50.0 100.0 kg , inclusive Good general health determine investigator medical history , physical examination , vital sign , electrocardiogram , baseline safety lab Personal family history bleeding disorder , reasonable suspicion vascular malformation , include aneurysm Known predisposition bleeding ( e.g . active peptic ulceration , recent ( within 6 month ) haemorrhagic stroke , proliferative diabetic retinopathy , poorly control hypertension ) Use antibiotic within thirty ( 30 ) day prior screen baseline visit Clinically significant abnormality medical history , physical examination , vital sign , electrocardiogram , baseline safety lab Supine pulse rate &gt; 100 beats/min &lt; 50 beats/min Systolic blood pressure &lt; 100 &gt; 140 mmHg Diastolic blood pressure &lt; 50 &gt; 90 mmHg Concomitant use medication include overthecounter preparation</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Healthy Volunteers</keyword>
</DOC>